BMED vs PPH

ABMED

BPPH

Measures won2–4PPH wins · of 6 · 5Y

$10,000 · 5Y$17,737PPH · BMED $12,148

Lowest cost0.36%PPH · $36 on $10k

Most income1.74%PPH · $174 on $10k

Smallest drop−10.8%PPH · worst fall in 1Y

Held in common12.6%BMED and PPH

iShares Health Innovation Active ETF · $15MVanEck Pharmaceutical ETF · $1.1B

+19.0%3 years · per year$16,849 · $16,788+18.8%

+4.0%5 years · per year$12,148 · $17,737+12.1%

0.77%Expense ratio$77 · $36 on $10k · lower wins0.36%

0.22%12-mo yield$22 · $174 on $10k1.74%

End-of-day Nov 13, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	BPPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.74%	+1.1%	+20.9%	+26.0%	+18.8%	+12.1%	−10.8%	$1.1B
2	ABMED	iShares Health Innovation Active ETFRead Desk		0.77%	0.22%	−0.2%	+20.2%	+24.4%	+19.0%	+4.0%	−14.9%	$15M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	BPPH	VanEck Pharmaceutical ETFRead Desk		0.36%	1.74%	+1.1%	+20.9%	+26.0%	+18.8%	+12.1%	−10.8%	$1.1B
2	ABMED	iShares Health Innovation Active ETFRead Desk		0.77%	0.22%	−0.2%	+20.2%	+24.4%	+19.0%	+4.0%	−14.9%	$15M

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

BMED

iShares Health Innovation Active

$12,148

PPH

VanEck Pharmaceutical

$17,737

Loading…